Although quantitative analysis of the CSF demonstrated that 18% of patients present intrathecal IgA synthesis (IAS)7, and qualitative analysis of these samples showed similar results8, there are not many reports about the role of IgA in MS patients. Here, CD79A is linked to myeloid sarcoma.